Old Web
English
Sign In
Acemap
>
authorDetail
>
Harold Bays
Harold Bays
Baylor College of Medicine
Medicine
World Wide Web
Kexin
Dose-ranging study
Subtilisin
3
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Correction to: Role of Bempedoic Acid in Clinical Practice.
2021
Cardiovascular Drugs and Therapy
Christie M. Ballantyne
Harold Bays
Alberico L. Catapano
Anne C. Goldberg
Kausik K. Ray
Joseph J. Saseen
Show All
Source
Cite
Save
Citations (0)
Save the Date — Call for Abstracts
2015
Michael Ozner
Christie Ballantyne
Harold Bays
Kevin Lenuell Billups
Michael J Blaha
Roger S Blumenthal
Michael Davidson
Italo Linfante
Vasanti Malik
Peter A. McCullough
Suzanne Oparil
Carl E. Orringer
Wendy S. Post
Goutham Rao
Show All
Source
Cite
Save
Citations (0)
=EFFICACY AND SAFETY OF BOCOCIZUMAB (RN316/PF-04950615), A MONOCLONAL ANTIBODY AGAINST PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 IN STATIN-TREATED HYPERCHOLESTEROLEMIC SUBJECTS: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY (NCT: 01592240)
2014
Journal of the American College of Cardiology
Christie M. Ballantyne
Joel Neutel
Anne Cropp
William Duggan
Ellen Wang
David Plowchalk
Kevin Sweeney
Nitin Kaila
John Vincent
Harold Bays
Show All
Source
Cite
Save
Citations (18)
1